Andere talen IRADIMED CORPORATION

Aandelen

IRMD

US46266A1097

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
43,85 ^USD	+4,40%		+5,74%	-7,63%

02/05	Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024
02/05	IRADIMED CORPORATION rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M	02/05
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q1 EPS $0.36	02/05
IRadimed: Q1 Earnings Snapshot	02/05
IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share	02/05
IRADIMED CORPORATION Declares Regular Quarterly Cash Dividend, Payable on May 30, 2024	02/05
IRADIMED CORPORATION Provides Revenue Guidance for the Second Quarter and Full Year of 2024	02/05
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd	25/04
IRadimed Files $75 Million Common Stock Shelf Registration	03/04
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference	13/03
IRadimed: Q4 Earnings Snapshot	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q4 Revenue $17.5M	08/02
Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q4 EPS $0.39	08/02
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results	08/02
IRadimed Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
IRadimed Corporation Provides Revenue Guidance for the First Quarter and Full Year of 2024	08/02
North American Morning Briefing : S&P 500 to Open -2-	08/02
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.	01/02
IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue	09/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen IRADIMED CORPORATION

Aandelen

IRMD

US46266A1097

Andere talen

Filters